BioMarin Pharmaceutical Inc. 0HNC.L
0HNC.L
BioMarin Pharmaceutical Inc. 0IJO.L
Exelixis, Inc. 0J2O.L
Halozyme Therapeutics, Inc. 0KHE.L
Revvity, Inc. 0JDI.L
Ionis Pharmaceuticals, Inc. 0I3Q.L
Corcept Therapeutics Incorporated 0K6R.L
Neurocrine Biosciences, Inc. 0HCK.L
Align Technology, Inc. 0I7E.L
DaVita Inc. 0QK8.L
Baxter International Inc.
BioMarin Pharmaceutical Inc. 0IJO.L
Exelixis, Inc. 0J2O.L
Halozyme Therapeutics, Inc. 0KHE.L
Revvity, Inc. 0JDI.L
Ionis Pharmaceuticals, Inc. 0I3Q.L
Corcept Therapeutics Incorporated 0K6R.L
Neurocrine Biosciences, Inc. 0HCK.L
Align Technology, Inc. 0I7E.L
DaVita Inc. 0QK8.L
Baxter International Inc.
Performance
| Periode | 0HNC.L | 0IJO.L | 0J2O.L | 0KHE.L | 0JDI.L | 0I3Q.L | 0K6R.L | 0HCK.L | 0I7E.L | 0QK8.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -17.94 % | 4.28 % | 8.73 % | 3.26 % | 143.80 % | -0.96 % | 39.62 % | -25.41 % | -7.23 % | -23.47 % |
| YTD | -21.80 % | 17.74 % | 35.05 % | -14.42 % | 106.54 % | 46.34 % | 7.07 % | -35.89 % | -14.85 % | -20.59 % |
| 1Y | -25.70 % | 39.95 % | 30.38 % | -17.60 % | 81.83 % | 49.95 % | 27.94 % | -38.24 % | -17.93 % | -35.64 % |
| 3Y | -38.49 % | 145.00 % | 36.51 % | -29.11 % | 67.32 % | 142.40 % | 29.40 % | -27.00 % | 81.30 % | -58.15 % |
| 5Y | -41.32 % | 117.48 % | 51.26 % | -23.97 % | 134.71 % | 324.13 % | 88.55 % | -73.28 % | -3.19 % | -70.15 % |
| 10Y | -41.32 % | 117.48 % | 248.05 % | 50.06 % | 134.71 % | 190.64 % | 88.55 % | -73.28 % | -3.19 % | -37.58 % |
| From the beginning | -41.32 % | 117.48 % | 248.05 % | 50.06 % | 134.71 % | 190.64 % | 88.55 % | -73.28 % | -3.19 % | -64.92 % |